Shares of Genus plc (LON:GNS – Get Free Report) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 2,383.60 and traded as high as GBX 2,645. Genus shares last traded at GBX 2,589.79, with a volume of 108,067 shares.
Analyst Ratings Changes
Several equities research analysts have issued reports on the company. Shore Capital raised their price target on Genus from GBX 2,900 to GBX 3,000 and gave the company a “buy” rating in a report on Wednesday, November 19th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Genus from GBX 2,900 to GBX 3,100 and gave the company a “buy” rating in a research report on Wednesday, November 19th. Finally, Berenberg Bank initiated coverage on shares of Genus in a research note on Tuesday, November 25th. They set a “buy” rating and a GBX 3,050 target price for the company. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of GBX 3,050.
Check Out Our Latest Report on GNS
Genus Price Performance
Genus (LON:GNS – Get Free Report) last announced its earnings results on Thursday, September 4th. The company reported GBX 81.80 earnings per share (EPS) for the quarter. Genus had a net margin of 1.18% and a return on equity of 1.41%. On average, equities research analysts anticipate that Genus plc will post 70.9644323 earnings per share for the current fiscal year.
Insider Transactions at Genus
In related news, insider Jorgen Kokke sold 3,450 shares of the stock in a transaction that occurred on Thursday, September 25th. The stock was sold at an average price of GBX 2,332, for a total transaction of £80,454. 0.70% of the stock is owned by corporate insiders.
Genus Company Profile
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Recommended Stories
- Five stocks we like better than Genus
- P/E Ratio Calculation: How to Assess Stocks
- 3 Stocks Poised to Benefit From Google’s AI Breakthough
- What is the MACD Indicator and How to Use it in Your Trading
- Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 Stocks You’ll Wish You Bought Before 2026
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
